Marvell Technology, Inc. (MRVL) NASDAQ
157.41
-6.9(-4.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
157.41
-6.9(-4.20%)
Currency In USD
| Previous Close | 164.31 |
| Open | 162.13 |
| Day High | 163.45 |
| Day Low | 151.09 |
| 52-Week High | 170.84 |
| 52-Week Low | 53.78 |
| Volume | 22.15M |
| Average Volume | 22.2M |
| Market Cap | 137.65B |
| PE | 51.27 |
| EPS | 3.07 |
| Moving Average 50 Days | 101.77 |
| Moving Average 200 Days | 86.25 |
| Change | -6.9 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX